Wednesday, March 14, 2018 House Floor Today Update

To authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes. (03/13/2018 legislative day)

This email was sent using GovDelivery Communications Cloud on behalf of: Library of Congress · 101 Independence Ave, SE · Washington, DC 20540 · 202-707-5000